Comment in Response to Proposed DEA Regulations on Telemedicine Access to Buprenorphine - O'Neill : O'Neill

March 31, 2023

The Addiction and Public Policy Initiative submitted comments in response to proposed DEA regulations on telemedicine access to buprenorphine.

Read the comments here.

Issues

Substance Use Disorder

Related Centers

Center on Addiction and Public Policy

Related Projects

Access to Evidence-Based Treatment for Substance Use Disorder

Latest publications See All

Comments

October 29, 2024

Comment to SAMSHA Proposed Data Collection Method

Op-Ed

October 28, 2024

A Look at the Supreme Court’s Upcoming Term

Journal Article

October 24, 2024

Power, data and social accountability: defining a community-led monitoring model for strengthened health service delivery